Amid disruption in Ukraine, international partnerships are preserving oncology progress—and building the foundation for long-term recovery.
Identifying ways to increase the proportion of patients with melanoma who have clinically meaningful and durable responses to immune...
Former Vice President Joe Biden returned to the stage at the American Association for Cancer Research (AACR) Annual Meeting...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
April symbolizes a progressive time for cancer researchers around the world. From April 1-5, over 20,000 cancer scientists will...
As part of a growing public affairs program, the American Association for Cancer Research is excited to once again...
A big career fair can be somewhat intimidating, so we asked some hiring experts for their advice on how...
At the 2017 Annual Meeting, the AACR is expanding its social media profile to include Snapchat and Instagram.
In addition to the robust scientific program at this year’s AACR Annual Meeting in Washington, D.C., a number of...
The U.S. Food and Drug Administration (FDA) has approved expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include...